Overview
Holoacardius amorphus (also known as acardiac amorphous twin) is an extremely rare condition that occurs in monochorionic twin pregnancies, representing the most severe form of the twin reversed arterial perfusion (TRAP) sequence. In this condition, one twin (the 'acardiac' or 'parasitic' twin) fails to develop a functioning heart and lacks recognizable body structures, appearing as an amorphous mass of tissue that may contain skin, connective tissue, bone fragments, cartilage, and occasionally rudimentary organs. This acardiac mass receives its blood supply from the normal ('pump') twin through abnormal arterial-arterial and venous-venous placental anastomoses, with blood flowing in a reversed direction. The primary clinical concern is the impact on the pump twin, whose heart must supply blood to both itself and the acardiac mass. This increased cardiac demand can lead to high-output cardiac failure, polyhydramnios (excess amniotic fluid), hydrops fetalis, preterm delivery, and potentially death of the pump twin. The condition is noted as 'OBSOLETE' in the Orphanet classification (code 2161), likely because it has been reclassified under the broader category of TRAP sequence or acardiac twinning. Management focuses on protecting the pump twin. Treatment options include expectant monitoring with serial ultrasound and echocardiography, and in cases where the pump twin shows signs of cardiac compromise, interventional procedures such as radiofrequency ablation, laser coagulation, or bipolar cord coagulation of the blood supply to the acardiac mass may be performed in utero. Early prenatal diagnosis through ultrasound is essential for appropriate management planning. No ICD-10 code is specifically assigned to this entity.
Sporadic
Usually appears on its own, not inherited from a parent
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for OBSOLETE: Holoacardius amorphus.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for OBSOLETE: Holoacardius amorphus at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for OBSOLETE: Holoacardius amorphus.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to OBSOLETE: Holoacardius amorphus.
Community
No community posts yet. Be the first to share your experience with OBSOLETE: Holoacardius amorphus.
Start the conversation →Latest news about OBSOLETE: Holoacardius amorphus
No recent news articles for OBSOLETE: Holoacardius amorphus.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about OBSOLETE: Holoacardius amorphus
What is OBSOLETE: Holoacardius amorphus?
Holoacardius amorphus (also known as acardiac amorphous twin) is an extremely rare condition that occurs in monochorionic twin pregnancies, representing the most severe form of the twin reversed arterial perfusion (TRAP) sequence. In this condition, one twin (the 'acardiac' or 'parasitic' twin) fails to develop a functioning heart and lacks recognizable body structures, appearing as an amorphous mass of tissue that may contain skin, connective tissue, bone fragments, cartilage, and occasionally rudimentary organs. This acardiac mass receives its blood supply from the normal ('pump') twin throu
How is OBSOLETE: Holoacardius amorphus inherited?
OBSOLETE: Holoacardius amorphus follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does OBSOLETE: Holoacardius amorphus typically begin?
Typical onset of OBSOLETE: Holoacardius amorphus is neonatal. Age of onset can vary across affected individuals.